Korean Drug Co., Ltd. (KOSDAQ: 014570)

Korean Drug Revenue

Korean Drug had revenue of 17.02B KRW in the quarter ending September 30, 2024, a decrease of -17.11%. This brings the company's revenue in the last twelve months to 74.41B, down -9.45% year-over-year. In the year 2023, Korean Drug had annual revenue of 81.37B with 1.74% growth.

• Revenue (ttm): 74.41B
• Revenue Growth: -9.45%
• P/S Ratio: 0.68
• Revenue / Employee: 275.59M
• Employees: 270
• Market Cap: 51.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	81.37B	1.39B	1.74%
Dec 31, 2022	79.98B	5.52B	7.41%
Dec 31, 2021	74.47B	7.68B	11.49%
Dec 31, 2020	66.79B	11.26B	20.28%
Dec 31, 2019	55.53B	3.50B	6.73%